Barbara Selisko
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Mapping the impact of 1'-, 2'- and 4'-nucleotide modifications on the Respiratory Syncytial Virus RNA-dependent RNA polymerase.
Journal: Antiviral research
Published: April 07, 2025
An exonuclease-resistant chain-terminating nucleotide analogue targeting the SARS-CoV-2 replicase complex.
Journal: Nucleic acids research
Published: August 25, 2023
AT-752 targets multiple sites and activities on the Dengue virus replication enzyme NS5.
Journal: Antiviral research
Published: November 20, 2022
Inhibition of Arenaviridae nucleoprotein exonuclease by bisphosphonate.
Journal: IUCrJ
Published: March 07, 2022
A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase.
Journal: Nature communications
Published: November 27, 2021
Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir.
Journal: ACS central science
Published: September 03, 2020
Synthesis and biological evaluation of novel flexible nucleoside analogues that inhibit flavivirus replication in vitro.
Journal: Bioorganic & medicinal chemistry
Published: July 23, 2020
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis.
Journal: Nature communications
Published: June 25, 2020
Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase.
Journal: bioRxiv : the preprint server for biology
Published: June 09, 2020
Last Updated: 09/26/2026